12:00 AM
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Deals

MorphoSys, OncoMed deal

MorphoSys received an undisclosed milestone payment from OncoMed under a 2006 deal to develop antibodies targeting cancer stem cells using MorphoSys' HuCAL GOLD library. The payment...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >